--- bibliography: 'morinlab.bib' csl: 'NLM.csl' link-citations: true --- [[_TOC_]] ## Overview GRHPR is one of [a number of genes](https://github.com/morinlab/LLMPP/wiki/ashm) affected by aberrant somatic hypermutation in B-cell lymphomas, which complicates the interpretation of mutations at this locus. The mutation pattern in DLBCL implies the preferential accumulation of *inactivating mutations*. Coding and non-coding mutations in GRHPR are a feature of the MCD genetic subgroup of DLBCL.[@arthurGenomewideDiscoverySomatic2018] Further research is needed to elucidate the specific role of GRHPR mutations in DLBCL. ## Relevance tier by entity |Entity|Tier|Description | |:------:|:----:|--------------------------| |![DLBCL](images/icons/DLBCL_tier1.png) |1 | aSHM target and high-confidence DLBCL gene[@arthurGenomewideDiscoverySomatic2018]| ## Mutation incidence in large patient cohorts (GAMBL reanalysis) [[include:DLBCL_GRHPR.md]] ## Mutation pattern and selective pressure estimates [[include:dnds_GRHPR.md]] ## aSHM regions |chr_name|hg19_start|hg19_end|region |regulatory_comment| |:--------:|:----------:|:--------:|:-----------------------------------------------------------------------------------------:|:------------------:| |chr9 |37423010 |37425279|[TSS](https://genome.ucsc.edu/s/rdmorin/GAMBL%20hg19?position=chr9%3A37423010%2D37425279)|active_promoter | [[include:browser_GRHPR.md]] ## Expression ![](images/gene_expression/GRHPR_by_pathology.svg) [[include:mermaid_GRHPR.md]] ## References